Germline Determinants of Esophageal Adenocarcinoma

Minyi Lee; George Eng; Anna Handte-Reinecker; MGH-MIT Gastrointestinal Cohorts Working Group; Vikram S Deshpande; Omer H Yilmaz; Manish K Gala

doi:10.1053/j.gastro.2023.07.015

Germline Determinants of Esophageal Adenocarcinoma

Gastroenterology. 2023 Nov;165(5):1276-1279.e7. doi: 10.1053/j.gastro.2023.07.015. Epub 2023 Jul 26.

Authors

Minyi Lee¹, George Eng², Anna Handte-Reinecker³; MGH-MIT Gastrointestinal Cohorts Working Group; Vikram S Deshpande¹¹, Omer H Yilmaz¹², Manish K Gala¹³

Collaborators

MGH-MIT Gastrointestinal Cohorts Working Group:
Alvin Jeon³, Eugeniu Stratulat³, Rachid Zagani³, Martin S Taylor⁴, Steffen Rickelt⁵, Dmitriy Kedrin³, Anupam Batra⁶, Ardeshir Hashmi⁷, Norman S Nishioka³, Chin Hur⁸, Lipika Goyal⁹, Fateh Bazerbachi¹⁰, Lawrence Zukerberg⁴

Affiliations

¹ Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; MD-PhD Program, Boston University School of Medicine, Boston, Massachusetts.
² Division of Gastroenterology and Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
³ Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
⁴ Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
⁵ David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
⁶ Massachusetts General Hospital Division of Senior Health and Harvard Medical School, Boston, Massachusetts; Department of Oncology, Cambridge Memorial Hospital, Cambridge, Ontario, Canada; Department of Oncology, Grand River Regional Cancer Center, Kitchener, Ontario, Canada.
⁷ Massachusetts General Hospital Division of Senior Health and Harvard Medical School, Boston, Massachusetts; Center for Geriatric Medicine, Cleveland Clinic, Cleveland, Ohio.
⁸ Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York; Division of Digestive and Liver Diseases, Columbia University Vagelos School of Medicine, New York, New York.
⁹ Division of Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.
¹⁰ Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Interventional Endoscopy Program, CentraCare and St. Cloud Hospital, St. Cloud, Minnesota.
¹¹ Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
¹² Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
¹³ Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: mgala@mgh.harvard.edu.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma* / genetics
Adenocarcinoma* / pathology
Esophageal Neoplasms* / genetics
Esophageal Neoplasms* / pathology
Humans

Supplementary concepts

Adenocarcinoma Of Esophagus

Publication types

MeSH terms

Supplementary concepts

Grants and funding